YZY Bio
Wuhan
About YZY Bio
YZY Bio is a biotechnology company that develops anti-tumor bispecific antibodies based on breakthrough discoveries in molecular biology, enabling patients with major diseases to obtain more efficient treatment solutions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $68.6M
- Funding stage: Late Stage Venture
- Last round: Series C (Jul 2022)
- Website: en.yzybio.com
- Phone: 86 27 82668988
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/yzy-bio-54547 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.